I agree that this site is using cookies. You can find further informations here.
X
Luttmann, Mark A
32  results:
Search for persons X
?
1

The COPD Foundation's COPD360Net Initiative Approach to Pat..:

Tal-Singer, Ruth ; Miller, Bruce E ; Rommes, Jean M...
Journal of Patient Experience.  10 (2023)  - p. 237437352311515 , 2023
Link: https://doi.org/10.1177/..
 
?
2

Pharmacological properties of revefenacin (TD‐4208), a nove..:

Hegde, Sharath S. ; Pulido‐Rios, M. Teresa ; Luttmann, Mark A....
Pharmacology Research & Perspectives.  6 (2018)  3 - p. , 2018
Link: https://doi.org/10.1002/..
 
?
3

Design, synthesis and structure–activity relationship of N-..:

Lainé, Dramane I. ; Yan, Hongxing ; Xie, Haibo...
Bioorganic & Medicinal Chemistry Letters.  22 (2012)  9 - p. 3366-3369 , 2012
Link: https://doi.org/10.1016/..
 
?
4

In vitro characterisation of the duration of action of the ..:

Slack, Robert J. ; Hart, Adam D. ; Luttmann, Mark A...
European Journal of Pharmacology.  670 (2011)  2-3 - p. 586-592 , 2011
Link: https://doi.org/10.1016/..
 
?
5

Design, Synthesis, and Structure−Activity Relationship of T..:

Lainé, Dramane I. ; Wan, Zehong ; Yan, Hongxing...
Journal of Medicinal Chemistry.  52 (2009)  16 - p. 5241-5252 , 2009
Link: https://doi.org/10.1021/..
 
?
6

Discovery of Novel 1-Azoniabicyclo[2.2.2]octane Muscarinic ..:

Lainé, Dramane I. ; McCleland, Brent ; Thomas, Sonia...
Journal of Medicinal Chemistry.  52 (2009)  8 - p. 2493-2505 , 2009
Link: https://doi.org/10.1021/..
 
?
7

A Highly Convergent Synthesis of 2‐Phenyl Quinoline as Dual..:

Yan, Hongxing ; Kerns, Jeffrey K. ; Jin, Qi...
Synthetic Communications.  35 (2005)  24 - p. 3105-3112 , 2005
Link: https://doi.org/10.1080/..
 
?
8

Stepwise Modulation of Neurokinin-3 and Neurokinin-2 Recept..:

Blaney, Frank E. ; Raveglia, Luca F. ; Artico, Marco...
Journal of Medicinal Chemistry.  44 (2001)  11 - p. 1675-1689 , 2001
Link: https://doi.org/10.1021/..
 
?
9

Molecular and pharmacological characterization of the murin..:

Sarau, Henry M ; Feild, John A ; Ames, Robert S...
European Journal of Pharmacology.  413 (2001)  2-3 - p. 143-150 , 2001
Link: https://doi.org/10.1016/..
 
?
10

Differential modulation of endothelin ligand-induced contra..:

Hay, Douglas W P ; Douglas, Stephen A ; Ao, Zhaohui...
British Journal of Pharmacology.  132 (2001)  8 - p. 1905-1915 , 2001
Link: https://doi.org/10.1038/..
 
?
11

Targeted Disruption of the Endothelin-B-Receptor Gene Atten..:

Griswold, Don E. ; Douglas, Stephen A ; Martin, Lenox D....
Journal of Cardiovascular Pharmacology.  36 (2000)  Supplement 1 - p. S78-S81 , 2000
Link: https://doi.org/10.1097/..
 
?
12

Human urotensin‐II is a potent spasmogen of primate airway ..:

Hay, Douglas W P ; Luttmann, Mark A ; Douglas, Stephen A
British Journal of Pharmacology.  131 (2000)  1 - p. 10-12 , 2000
Link: https://doi.org/10.1038/..
 
?
13

Targeted Disruption of the Endothelin-B-Receptor Gene Atten..:

Griswold, Don E. ; Douglas, Stephen A ; Martin, Lenox D....
Journal of Cardiovascular Pharmacology.  36 (2000)  - p. S78-S81 , 2000
Link: https://doi.org/10.1097/..
 
?
14

Cysteinyl Leukotriene Receptor Assays:

Muccitelli, Roseanna M. ; Luttmann, Mark A. ; Hay, Douglas W.P.
Current Protocols in Pharmacology.  9 (2000)  1 - p. , 2000
Link: https://doi.org/10.1002/..
 
?
15

Discovery of a Novel Class of Selective Non-Peptide Antagon..:

Giardina, Giuseppe A. M. ; Raveglia, Luca F. ; Grugni, Mario...
Journal of Medicinal Chemistry.  42 (1999)  6 - p. 1053-1065 , 1999
Link: https://doi.org/10.1021/..
 
1-15